Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Philippe Brouqui and Philippe Gautret.
Philippe Brouqui
Connection Strength
5.940
Philippe Gautret
  1. Hajj pilgrims knowledge about Middle East respiratory syndrome coronavirus, August to September 2013. Euro Surveill. 2013 Oct 10; 18(41):20604.
    View in: PubMed
    Score: 0.558
  2. Preventive measures against MERS-CoV for Hajj pilgrims. Lancet Infect Dis. 2013 Oct; 13(10):829-31.
    View in: PubMed
    Score: 0.557
  3. Asymptomatic hypoxia in COVID-19 is associated with poor outcome. Int J Infect Dis. 2021 Jan; 102:233-238.
    View in: PubMed
    Score: 0.455
  4. Common health hazards in French pilgrims during the Hajj of 2007: a prospective cohort study. J Travel Med. 2009 Nov-Dec; 16(6):377-81.
    View in: PubMed
    Score: 0.425
  5. COVID-19 re-infection. Eur J Clin Invest. 2021 May; 51(5):e13537.
    View in: PubMed
    Score: 0.234
  6. Natural history of COVID-19 and therapeutic options. Expert Rev Clin Immunol. 2020 12; 16(12):1159-1184.
    View in: PubMed
    Score: 0.230
  7. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med Infect Dis. 2020 Mar - Apr; 34:101663.
    View in: PubMed
    Score: 0.219
  8. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Jul; 56(1):105949.
    View in: PubMed
    Score: 0.218
  9. Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot. Travel Med Infect Dis. 2020 Jul - Aug; 36:101632.
    View in: PubMed
    Score: 0.218
  10. Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine? Travel Med Infect Dis. 2020 Mar - Apr; 34:101624.
    View in: PubMed
    Score: 0.218
  11. Travelers' Actual and Subjective Knowledge about Risk for Ebola Virus Disease. Emerg Infect Dis. 2018 09; 24(9):1750-1751.
    View in: PubMed
    Score: 0.196
  12. Epidemiology of respiratory pathogen carriage in the homeless population within two shelters in Marseille, France, 2015-2017: cross sectional 1-day surveys. Clin Microbiol Infect. 2019 Feb; 25(2):249.e1-249.e6.
    View in: PubMed
    Score: 0.192
  13. Surveillance of travel-associated diseases at two referral centres in Marseille, France: a 12-year survey. J Travel Med. 2018 01 01; 25(1).
    View in: PubMed
    Score: 0.187
  14. Changing Demographics and Prevalence of Body Lice among Homeless Persons, Marseille, France. Emerg Infect Dis. 2017 11; 23(11):1894-1897.
    View in: PubMed
    Score: 0.185
  15. Infections in symptomatic travelers returning from the Arabian peninsula to France: A retrospective cross-sectional study. Travel Med Infect Dis. 2016 Jul-Aug; 14(4):414-6.
    View in: PubMed
    Score: 0.167
  16. Imported cases of Middle East respiratory syndrome: an update. Travel Med Infect Dis. 2015 Jan-Feb; 13(1):106-9.
    View in: PubMed
    Score: 0.151
  17. Respiratory viruses and bacteria among pilgrims during the 2013 Hajj. Emerg Infect Dis. 2014 Nov; 20(11):1821-7.
    View in: PubMed
    Score: 0.150
  18. Lack of MERS coronavirus but prevalence of influenza virus in French pilgrims after 2013 Hajj. Emerg Infect Dis. 2014 Apr; 20(4):728-30.
    View in: PubMed
    Score: 0.144
  19. Lack of nasal carriage of novel corona virus (HCoV-EMC) in French Hajj pilgrims returning from the Hajj 2012, despite a high rate of respiratory symptoms. Clin Microbiol Infect. 2013 Jul; 19(7):E315-7.
    View in: PubMed
    Score: 0.134
  20. Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients. Front Immunol. 2021; 12:625732.
    View in: PubMed
    Score: 0.119
  21. Olfactory and gustative disorders for the diagnosis of COVID-19. Travel Med Infect Dis. 2020 Sep - Oct; 37:101875.
    View in: PubMed
    Score: 0.113
  22. Malaria, tuberculosis and HIV: what's new? Contribution of the Institut Hospitalo-Universitaire Méditerranée Infection in updated data. New Microbes New Infect. 2018 Nov; 26:S23-S30.
    View in: PubMed
    Score: 0.097
  23. From Expert Protocols to Standardized Management of Infectious Diseases. Clin Infect Dis. 2017 Aug 15; 65(suppl_1):S12-S19.
    View in: PubMed
    Score: 0.091
  24. Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity. Microb Drug Resist. 2021 Mar; 27(3):281-290.
    View in: PubMed
    Score: 0.058
  25. Correction to: Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19. Insights Imaging. 2021 Feb 16; 12(1):21.
    View in: PubMed
    Score: 0.058
  26. Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19. Insights Imaging. 2020 Nov 17; 11(1):117.
    View in: PubMed
    Score: 0.057
  27. Evaluating the serological status of COVID-19 patients using an indirect immunofluorescent assay, France. Eur J Clin Microbiol Infect Dis. 2021 Feb; 40(2):361-371.
    View in: PubMed
    Score: 0.057
  28. Low-dose chest CT for diagnosing and assessing the extent of lung involvement of SARS-CoV-2 pneumonia using a semi quantitative score. PLoS One. 2020; 15(11):e0241407.
    View in: PubMed
    Score: 0.057
  29. Children account for a small proportion of diagnoses of SARS-CoV-2 infection and do not exhibit greater viral loads than adults. Eur J Clin Microbiol Infect Dis. 2020 Oct; 39(10):1983-1987.
    View in: PubMed
    Score: 0.056
  30. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Travel Med Infect Dis. 2020 Jul - Aug; 36:101791.
    View in: PubMed
    Score: 0.056
  31. Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world. New Microbes New Infect. 2020 Nov; 38:100709.
    View in: PubMed
    Score: 0.055
  32. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis. 2020 May - Jun; 35:101738.
    View in: PubMed
    Score: 0.055
  33. Rickettsia slovaca and R. raoultii in tick-borne Rickettsioses. Emerg Infect Dis. 2009 Jul; 15(7):1105-8.
    View in: PubMed
    Score: 0.052
  34. West Nile virus outbreak in the South of France: Implications for travel medicine. Travel Med Infect Dis. 2019 Mar - Apr; 28:100-101.
    View in: PubMed
    Score: 0.050
  35. Identification of dengue type 2 virus in febrile travellers returning from Burkina Faso to France, related to an ongoing outbreak, October to November 2016. Euro Surveill. 2016 Dec 15; 21(50).
    View in: PubMed
    Score: 0.044
  36. Prevalence of antibodies to Rickettsia conorii Ricketsia africae, Rickettsia typhi and Coxiella burnetii in Mauritania. Eur J Epidemiol. 1998 Dec; 14(8):817-8.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.